Q2 Earnings Forecast for UNCY Issued By Noble Financial
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Free Report) – Stock analysts at Noble Financial issued their Q2 2025 earnings estimates for Unicycive Therapeutics in a research note issued to investors on Thursday, May 15th. Noble Financial analyst R. Leboyer expects that the company will earn ($0.07) per share for the quarter. The consensus estimate for Unicycive […]
